ALTEOGEN Inc.

KOSDAQ:A196170 Stock Report

Market Cap: ₩19.7t

ALTEOGEN Future Growth

Future criteria checks 6/6

ALTEOGEN is forecast to grow earnings and revenue by 41.4% and 43.9% per annum respectively. EPS is expected to grow by 43% per annum. Return on equity is forecast to be 44.3% in 3 years.

Key information

41.4%

Earnings growth rate

42.97%

EPS growth rate

Biotechs earnings growth34.1%
Revenue growth rate43.9%
Future return on equity44.27%
Analyst coverage

Low

Last updated20 May 2026

Recent future growth updates

Recent updates

Analysis Article • Apr 07

News Flash: 4 Analysts Think ALTEOGEN Inc. (KOSDAQ:196170) Earnings Are Under Threat

Today is shaping up negative for ALTEOGEN Inc. ( KOSDAQ:196170 ) shareholders, with the analysts delivering a...
Analysis Article • Feb 14

We Think ALTEOGEN (KOSDAQ:196170) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Nov 26

ALTEOGEN's (KOSDAQ:196170) Solid Profits Have Weak Fundamentals

ALTEOGEN Inc. ( KOSDAQ:196170 ) announced strong profits, but the stock was stagnant. Our analysis suggests that...
Analysis Article • Jun 26

Estimating The Fair Value Of ALTEOGEN Inc. (KOSDAQ:196170)

Key Insights Using the 2 Stage Free Cash Flow to Equity, ALTEOGEN fair value estimate is ₩340,851 Current share price...
Analysis Article • Jun 02

Is Now The Time To Put ALTEOGEN (KOSDAQ:196170) On Your Watchlist?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Earnings and Revenue Growth Forecasts

KOSDAQ:A196170 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028989,835584,250470,850548,5503
12/31/2027753,589493,573354,903445,8005
12/31/2026441,010299,950238,467281,2503
12/31/2025215,859141,66690,710124,127N/A
9/30/2025202,182125,92660,73582,161N/A
6/30/2025158,05994,28866,54886,532N/A
3/31/2025151,650124,463-15,5187,409N/A
12/31/2024102,85562,25228,59853,044N/A
9/30/202474,375-2,906-7,01321,653N/A
6/30/202490,788-1,282-14,49716,054N/A
3/31/2024121,08725,542-1,80731,966N/A
12/31/202396,523-3,372-48,235-7,766N/A
9/30/202385,0366,459-47,997-5,918N/A
6/30/202369,1547,865-54,448-10,137N/A
3/31/202332,199-21,798-65,152-17,104N/A
12/31/202228,806-8,146-60,366-17,875N/A
9/30/202232,2921,367-48,159-3,432N/A
6/30/202233,065-223-38,075-3,080N/A
3/31/202233,807-1,243-36,477-6,327N/A
12/31/202138,746-6,275-33,536-9,461N/A
9/30/202129,498-38,971-38,304-24,242N/A
6/30/202137,316-26,975-13,157600N/A
3/31/202144,433-17,748-5,171147N/A
12/31/202042,426-15,822-4,0161,512N/A
9/30/202051,93515,42414,53721,726N/A
6/30/202043,4209,040-2,9915,475N/A
3/31/202035,2425,001-1039,187N/A
12/31/201929,229-7058049,133N/A
9/30/201918,012-7,900N/A-7,301N/A
6/30/201915,796-8,574N/A-8,421N/A
3/31/201913,473-8,078N/A-7,995N/A
12/31/201813,703-6,872N/A-9,113N/A
9/30/201813,079-11,776N/A-8,027N/A
6/30/201812,610-9,945N/A-7,065N/A
3/31/201811,788-10,332N/A-6,763N/A
12/31/201712,104-7,449N/A-4,347N/A
9/30/201711,815-2,837N/A-6,028N/A
6/30/201711,567-2,871N/A-1,809N/A
3/31/201710,569-1,961N/A-2,797N/A
12/31/20166,844-3,587N/A-3,159N/A
9/30/20166,088-1,481N/A1,869N/A
6/30/20164,213-201N/A-902N/A
3/31/20163,634-136N/A1,726N/A
12/31/20154,7271,208N/A2,264N/A
9/30/20154,585337N/A1,210N/A
6/30/20155,686320N/A2,476N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A196170's forecast earnings growth (41.4% per year) is above the savings rate (3.1%).

Earnings vs Market: A196170's earnings (41.4% per year) are forecast to grow faster than the KR market (31.5% per year).

High Growth Earnings: A196170's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A196170's revenue (43.9% per year) is forecast to grow faster than the KR market (15.8% per year).

High Growth Revenue: A196170's revenue (43.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A196170's Return on Equity is forecast to be very high in 3 years time (44.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/29 06:12
End of Day Share Price 2026/05/29 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ALTEOGEN Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyonseok KimCLSA
null nullDBS Bank Ltd
Haesoon KwonEugene Investment & Securities Co Ltd.